Compare OFRM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OFRM | PRME |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | 153 | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 684.3M | 666.1M |
| IPO Year | N/A | 2022 |
| Metric | OFRM | PRME |
|---|---|---|
| Price | $15.89 | $3.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $27.75 | $7.56 |
| AVG Volume (30 Days) | 574.4K | ★ 2.1M |
| Earning Date | 05-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | $29.42 | $12.41 |
| Revenue Next Year | $34.69 | $52.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $14.30 | $1.11 |
| 52 Week High | $27.00 | $6.94 |
| Indicator | OFRM | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 52.52 |
| Support Level | $15.76 | $3.17 |
| Resistance Level | $17.20 | $3.94 |
| Average True Range (ATR) | 1.00 | 0.26 |
| MACD | 0.20 | 0.05 |
| Stochastic Oscillator | 55.34 | 77.71 |
Once Upon a Farm PBC is a provider of baby food products. The company provides childhood nutrition with real, organic, farm-fresh food-made with no added sugar, no preservatives, and nothing artificial. Its products are available at retail customers, including Target, Whole Foods, Kroger, Walmart, Publix, and Wegmans. Its key products include Smoothies, Yogurt, Milk Shakes, Oat Bars, etc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.